Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v3-EN
Language English English
Date Updated 2021-04-01 2021-04-01
Drug Identification Number 00030708 00030708
Brand name BACITRACIN USP BACITRACIN USP
Common or Proper name BACITRACIN USP BACITRACIN USP
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients BACITRACIN BACITRACIN
Strength(s) 50000UNIT 50000UNIT
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR TOPICAL INTRAMUSCULAR TOPICAL INTRAMUSCULAR TOPICAL INTRAMUSCULAR TOPICAL
Packaging size 5 x 30mL vial 5 x 30mL vial
ATC code J01XX J01XX
ATC description OTHER ANTIBACTERIALS OTHER ANTIBACTERIALS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2021-03-31 2021-03-31
Remaining supply date 2021-03-31 2021-03-31
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments